Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT1 | P26358 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | APAF1 | O14727 | 2/20 | 0.33 |
| ▸ | TDP2 | O95551 | 2/20 | 0.33 |
| ▸ | NSD2 | O96028 | 2/20 | 0.33 |
| ▸ | HKDC1 | Q2TB90 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | GALK1 | P51570 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.32 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triaziquone SCHEMBL6830995 | 0.95 | DNMT1 (0.39) | DNMT1TP53MAPTSTAT3HTT | |
| Triaziquone SCHEMBL610295 | 0.93 | DNMT1 (0.42) | DNMT1TP53MAPTSTAT3HTT | |
| Triaziquone SCHEMBL10379983 | 0.91 | DNMT1 (0.41) | DNMT1TP53MAPTSTAT3HTT | |
| Triaziquone SCHEMBL2160619 | 0.91 | DNMT1 (0.41) | DNMT1TP53MAPTSTAT3HTT | |
| Triaziquone SCHEMBL11416072 | 0.89 | DNMT1 (0.40) | DNMT1TP53MAPTSTAT3HTT | |
| Triaziquone SCHEMBL11793180 | 0.89 | TP53 (0.36) | DNMT1TP53MAPTSTAT3HTT | |
| Triaziquone SCHEMBL11644813 | 0.89 | DNMT1 (0.35) | DNMT1TP53MAPTSTAT3HTT | |
| Triaziquone SCHEMBL1961248 | 0.88 | DNMT1 (0.39) | DNMT1TP53MAPTSTAT3HTT | |
| Triaziquone SCHEMBL9319019 | 0.88 | DNM1 (0.38) | DNMT1TP53MAPTSTAT3HTT | |
| Octadecylamine SCHEMBL11308593 | 0.88 | DNM1 (0.38) | DNMT1TP53MAPTSTAT3HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120041088-A1 | FOAMING ADDITIVE FOR PRODUCING POLYURETHANE FOAM, AND METHOD FOR PRODUCING RIGID POLYURETHANE FOAM BY USING IT | TOSOH CORPORATION (JP) | 2012-02-16 | — | — | US | claimed |
| US-20260148990-A1 | BINDER FOR NEGATIVE ELECTRODE OF RECHARGEABLE LITHIUM BATTERY, NEGATIVE ELECTRODE FOR RECHARGEABLE LITHIUM BATTERY INCLUDING BINDER, AND RECHARGEABLE LITHIUM BATTERY INCLUDING NEGATIVE ELECTRODE | SAMSUNG SDI CO., LTD. (KR) | 2026-05-28 | — | — | US | disclosed |
| EP-4135890-A1 | SORBENT CELLULOSIC MATERIALS BASED ON LOW MOLECULAR WEIGHT AMINE SURFACE FUNCTIONALISATION | Puraffinity Ltd (GB) | 2023-02-22 | — | — | EP | disclosed |
| WO-2021209774-A1 | SORBENT CELLULOSIC MATERIALS BASED ON LOW MOLECULAR WEIGHT AMINE SURFACE FUNCTIONALISATION | PURAFFINITY LTD (GB) | 2021-10-21 | — | — | WO | disclosed |
| CN-113164915-A | Solid phase chelator material, method for the production thereof and use thereof for the purification of proteins | 库贝生物科技有限公司 | 2021-07-23 | — | — | CN | disclosed |
| US-20200071483-A1 | SCALABLE MANUFACTURING METHOD OF PROPERTY-TAILORABLE POLYUREA FOAM | SAN DIEGO STATE UNIVERSITY RESEARCH FOUNDATION | 2020-03-05 | — | — | US | disclosed |
| CN-104284858-A | Formation of conjugated protein by electrospinning | PEPSICO INC | 2015-01-14 | — | — | CN | disclosed |
| US-8765008-B2 | Hydroxyalkylated polyalkylenepolyamine composition, method for producing same and method for producing polyurethane resin using such hydroxyalkylated polyalkylenepolyamine composition | TOSOH CORPORATION (JP) | 2014-07-01 | — | — | US | disclosed |
| US-20120252661-A1 | HYDROXYALKYLATED POLYALKYLENEPOLYAMINE COMPOSITION, METHOD FOR PRODUCING SAME AND METHOD FOR PRODUCING POLYURETHANE RESIN USING SUCH HYDROXYALKYLATED POLYALKYLENEPOLYAMINE COMPOSITION | TOSOH CORPORATION (JP) | 2012-10-04 | — | — | US | disclosed |
| US-8222311-B2 | Hydroxyalkylated polyalkylenepolyamine composition, method of producing the same and their use in polyurethanes | TOSOH CORPORATION (JP) | 2012-07-17 | — | — | US | disclosed |
| US-20120041088-A1 | FOAMING ADDITIVE FOR PRODUCING POLYURETHANE FOAM, AND METHOD FOR PRODUCING RIGID POLYURETHANE FOAM BY USING IT | TOSOH CORPORATION (JP) | 2012-02-16 | — | — | US | disclosed |
| US-20080004362-A1 | Hydroxyalkylated Polyalkylenepolyamine Composition, Method for Producing Same and Method for Producing Polyurethane Resin Using Such Hydroxyalkylated Polyalkylenepolyamine Composition | TOSOCH CORPORATION (JP) | 2008-01-03 | — | — | US | disclosed |
| EP-1813599-A1 | HYDROXYALKYLATED POLYALKYLENEPOLYAMINE COMPOSITION, METHOD FOR PRODUCING SAME AND METHOD FOR PRODUCING POLYURETHANE RESIN USING SUCH HYDROXYALKYLATED POLYALKYLENEPOLYAMINE COMPOSITION | Tosoh Corporation (JP) | 2007-08-01 | — | — | EP | disclosed |
| US-20020094316-A1 | Polypodal chelants for metallopharmaceuticals | BRISTOL-MYERS SQUIBB PHARMA COMPANY (FORMERLY D/B/A DUPONT PHARMACEUTICALS COMPANY) | 2002-07-18 | — | — | US | disclosed |
| EP-0836629-A4 | AQUEOUS COATING COMPOSITION | LINE PRODUCTS CORP A (US) | 1999-03-24 | — | — | EP | disclosed |
| US-5880190-A | MIXTURE OF POLYOL, HALOGENATED RESIN, SURFACTANT, AMINE, ACRYLIC/POLYURETHANE DISPERSION, WATER; FREE OF AROMATIC ORGANIC SOLVENTS | A-LINE PRODUCTS CORPORATION (US) | 1999-03-09 | — | — | US | disclosed |
| EP-0836629-A1 | AQUEOUS COATING COMPOSITION | A-LINE PRODUCTS CORPORATION (US) | 1998-04-22 | — | — | EP | disclosed |
| US-5696071-A | Tris (3-aminopropyl)amine derivative and detergent composition containing the same | KAO CORPORATION (JP) | 1997-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080004362-A1 | Hydroxyalkylated Polyalkylenepolyamine Composition, Method for Producing Same and Method for Producing Polyurethane Resin Using Such Hydroxyalkylated Polyalkylenepolyamine Composition | SRM, HRH3, HNMT | DNMT1 760/4885TP53 4210/4885MAPT 3900/4885 |
| US-20020094316-A1 | Polypodal chelants for metallopharmaceuticals | CLTC, SLC39A14, CLTB | DNMT1 551/4885TP53 286/4885MAPT 1063/4885 |
| US-20260148990-A1 | BINDER FOR NEGATIVE ELECTRODE OF RECHARGEABLE LITHIUM BATTERY, NEGATIVE ELECTRODE FOR RECHARGEABLE LITHIUM BATTERY INCLUDING BINDER, AND RECHARGEABLE LITHIUM BATTERY INCLUDING NEGATIVE ELECTRODE | LBR, RCOR1, SLC9A1 | DNMT1 843/4885TP53 3397/4885MAPT 2796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.